John Arigo, PhD

Dr. John Arigo is Division Director of the Division of Pharmaceutical Manufacturing Assessment 2 in the Office of Pharmaceutical Manufacturing Assessment (OPMA), Office of Pharmaceutical Quality (OPQ) at the U.S. Food and Drug Administration. With 18 years at FDA, Dr. Arigo has progressed through multiple roles including reviewer, team leader, and branch chief, gaining comprehensive expertise across pharmaceutical manufacturing oversight. Dr. Arigo holds a Ph.D. in Biochemistry, Cellular and Molecular Biology from The Johns Hopkins School of Medicine and a bachelor's degree in Microbiology from the University of Maryland. His areas of expertise include sterility assurance and emerging technology assessment. As a member of FDA's Emerging Technology Team, Dr. Arigo works at the forefront of evaluating novel manufacturing approaches and technologies in pharmaceutical production.